EMEA-002656-PIP01-19-M01 - paediatric investigation plan

Chikungunya Virus Virus-Like Particle Vaccine / aluminum hydroxide

Key facts

• Active Substance:
  Chikungunya Virus Virus-Like Particle Vaccine / aluminum hydroxide
• Therapeutic area:
  • Infections and infestations
  • Vaccines
• Decision number:
  P/0059/2024
• PIP number:
  EMEA-002656-PIP01-19-M01
• Pharmaceutical form(s):
  Suspension for injection
• Condition(s) / indication(s):
  Prevention of chikungunya disease
• Route(s) of administration:
  Intramuscular use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  07/03/2024

Decision

P/0059/2024 : EMA decision of 7 March 2024 on the acceptance of a modification of an agreed paediatric investigation plan for Chikungunya virus virus-like particle vaccine / aluminum hydroxide (EMEA-002656-PIP01-19-M01)

AdoptedReference Number: EMA/81544/2024